1. Home
  2. CYTK vs SOBO Comparison

CYTK vs SOBO Comparison

Compare CYTK & SOBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • SOBO
  • Stock Information
  • Founded
  • CYTK 1997
  • SOBO 2024
  • Country
  • CYTK United States
  • SOBO Canada
  • Employees
  • CYTK N/A
  • SOBO N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • SOBO
  • Sector
  • CYTK Health Care
  • SOBO
  • Exchange
  • CYTK Nasdaq
  • SOBO NYSE
  • Market Cap
  • CYTK 6.0B
  • SOBO 4.9B
  • IPO Year
  • CYTK 2004
  • SOBO N/A
  • Fundamental
  • Price
  • CYTK $48.13
  • SOBO $26.70
  • Analyst Decision
  • CYTK Buy
  • SOBO
  • Analyst Count
  • CYTK 16
  • SOBO 0
  • Target Price
  • CYTK $83.67
  • SOBO N/A
  • AVG Volume (30 Days)
  • CYTK 1.2M
  • SOBO 557.0K
  • Earning Date
  • CYTK 11-06-2024
  • SOBO 01-01-0001
  • Dividend Yield
  • CYTK N/A
  • SOBO N/A
  • EPS Growth
  • CYTK N/A
  • SOBO N/A
  • EPS
  • CYTK N/A
  • SOBO N/A
  • Revenue
  • CYTK $3,219,000.00
  • SOBO N/A
  • Revenue This Year
  • CYTK N/A
  • SOBO N/A
  • Revenue Next Year
  • CYTK $911.39
  • SOBO N/A
  • P/E Ratio
  • CYTK N/A
  • SOBO N/A
  • Revenue Growth
  • CYTK N/A
  • SOBO N/A
  • 52 Week Low
  • CYTK $30.68
  • SOBO $21.12
  • 52 Week High
  • CYTK $110.25
  • SOBO $27.30
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 39.67
  • SOBO N/A
  • Support Level
  • CYTK $49.64
  • SOBO N/A
  • Resistance Level
  • CYTK $59.39
  • SOBO N/A
  • Average True Range (ATR)
  • CYTK 2.23
  • SOBO 0.00
  • MACD
  • CYTK -0.54
  • SOBO 0.00
  • Stochastic Oscillator
  • CYTK 4.88
  • SOBO 0.00

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About SOBO SOUTH BOW CORPORATION

South Bow Corp is a energy infrastructure company. The company is engaged in constructing pipelines system safely transports liquids like crude oil, across Canadian provinces, U.S. states, and Gulf coasts.

Share on Social Networks: